170 related articles for article (PubMed ID: 27534532)
61. HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1.
Moses N; Zhang M; Wu JY; Hu C; Xiang S; Geng X; Chen Y; Bai W; Zhang YW; Bepler G; Zhang XM
Cells; 2020 Oct; 9(10):. PubMed ID: 33020410
[TBL] [Abstract][Full Text] [Related]
62. Histone deacetylase 6 is overexpressed and promotes tumor growth of colon cancer through regulation of the MAPK/ERK signal pathway.
Zhang SL; Zhu HY; Zhou BY; Chu Y; Huo JR; Tan YY; Liu DL
Onco Targets Ther; 2019; 12():2409-2419. PubMed ID: 31118659
[No Abstract] [Full Text] [Related]
63. The protein farnesyltransferase regulates HDAC6 activity in a microtubule-dependent manner.
Zhou J; Vos CC; Gjyrezi A; Yoshida M; Khuri FR; Tamanoi F; Giannakakou P
J Biol Chem; 2009 Apr; 284(15):9648-55. PubMed ID: 19228685
[TBL] [Abstract][Full Text] [Related]
64. HDAC6-dependent deacetylation of AKAP12 dictates its ubiquitination and promotes colon cancer metastasis.
Deng Y; Gao J; Xu G; Yao Y; Sun Y; Shi Y; Hao X; Niu L; Li H
Cancer Lett; 2022 Nov; 549():215911. PubMed ID: 36122629
[TBL] [Abstract][Full Text] [Related]
65. SET7 interacts with HDAC6 and suppresses the development of colon cancer through inactivation of HDAC6.
Zhang SL; Du X; Tan LN; Deng FH; Zhou BY; Zhou HJ; Zhu HY; Chu Y; Liu DL; Tan YY
Am J Transl Res; 2020; 12(2):602-611. PubMed ID: 32194908
[TBL] [Abstract][Full Text] [Related]
66. Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6.
Wu X; Zhang X; Liu P; Wang Y
Pancreatology; 2023 Sep; 23(6):630-641. PubMed ID: 37460341
[TBL] [Abstract][Full Text] [Related]
67. HDAC6 promotes growth, migration/invasion, and self-renewal of rhabdomyosarcoma.
Pham TQ; Robinson K; Xu L; Pavlova MN; Skapek SX; Chen EY
Oncogene; 2021 Jan; 40(3):578-591. PubMed ID: 33199827
[TBL] [Abstract][Full Text] [Related]
68. RASSF1A Suppresses Cell Migration through Inactivation of HDAC6 and Increase of Acetylated α-Tubulin.
Jung HY; Jung JS; Whang YM; Kim YH
Cancer Res Treat; 2013 Jun; 45(2):134-44. PubMed ID: 23864847
[TBL] [Abstract][Full Text] [Related]
69. Suppressing migration and invasion of H1299 lung cancer cells by honokiol through disrupting expression of an HDAC6-mediated matrix metalloproteinase 9.
Pai JT; Hsu CY; Hsieh YS; Tsai TY; Hua KT; Weng MS
Food Sci Nutr; 2020 Mar; 8(3):1534-1545. PubMed ID: 32180962
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of HDAC6 Attenuates Tumor Growth of Non-Small Cell Lung Cancer.
Deskin B; Yin Q; Zhuang Y; Saito S; Shan B; Lasky JA
Transl Oncol; 2020 Feb; 13(2):135-145. PubMed ID: 31865176
[TBL] [Abstract][Full Text] [Related]
71. HDAC6 at Crossroads of Infection and Innate Immunity.
Moreno-Gonzalo O; Mayor F; Sánchez-Madrid F
Trends Immunol; 2018 Aug; 39(8):591-595. PubMed ID: 29937401
[TBL] [Abstract][Full Text] [Related]
72. HDAC6-dependent deacetylation of TAK1 enhances sIL-6R release to promote macrophage M2 polarization in colon cancer.
Xu G; Niu L; Wang Y; Yang G; Zhu X; Yao Y; Zhao G; Wang S; Li H
Cell Death Dis; 2022 Oct; 13(10):888. PubMed ID: 36270986
[TBL] [Abstract][Full Text] [Related]
73. HDAC6 and ERK/ADAM17 Regulate VEGF-Induced NOTCH Signaling in Lung Endothelial Cells.
Xia S; Menden HL; Mabry SM; Sampath V
Cells; 2023 Sep; 12(18):. PubMed ID: 37759454
[TBL] [Abstract][Full Text] [Related]
74. Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer.
Zhou B; Liu D; Tan Y
Front Cell Dev Biol; 2021; 9():719390. PubMed ID: 34938729
[TBL] [Abstract][Full Text] [Related]
75. HDAC6 as a potential therapeutic target for peripheral nerve disorders.
Prior R; Van Helleputte L; Klingl YE; Van Den Bosch L
Expert Opin Ther Targets; 2018 Dec; 22(12):993-1007. PubMed ID: 30360671
[TBL] [Abstract][Full Text] [Related]
76. Effect of ethanol extracts of Hericium erinaceus mycelium on morphine‑induced microglial migration.
Yeh CH; Sun LW; Lai CM; Yeh TP; Lin JN; Tsay SL; Chen CC; Chen WP; Chen CM; Tsai RY
Mol Med Rep; 2019 Dec; 20(6):5279-5285. PubMed ID: 31638202
[TBL] [Abstract][Full Text] [Related]
77. Regulation of cellular contractile force, shape and migration of fibroblasts by oncogenes and Histone deacetylase 6.
López-Guajardo A; Zafar A; Al Hennawi K; Rossi V; Alrwaili A; Medcalf JD; Dunning M; Nordgren N; Pettersson T; Estabrook ID; Hawkins RJ; Gad AKB
Front Mol Biosci; 2023; 10():1197814. PubMed ID: 37564130
[TBL] [Abstract][Full Text] [Related]
78. HDAC6 promotes aggressive development of liver cancer by improving egfr mRNA stability.
Dai HY; Chang LS; Yang SF; Wang SN; Su SJ; Yeh YT
Neoplasia; 2023 Jan; 35():100845. PubMed ID: 36334332
[No Abstract] [Full Text] [Related]
79. HDAC6 score: to treat or not to treat?
Hey J; Llamazares Prada M; Plass C
Nat Cancer; 2023 Feb; 4(2):156-158. PubMed ID: 36585451
[No Abstract] [Full Text] [Related]
80. A role for HDAC6 in leptin sensitivity.
Greenhill C
Nat Rev Endocrinol; 2022 Apr; 18(4):194. PubMed ID: 35102295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
